Radiopharm Theranostics Limited (RDPTF) Operating cash flow 2023–2025
Radiopharm Theranostics Limited (RDPTF) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$36.6MFY2025 · since FY2023: -$23.2M → -$36.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$36.6M | -59.5% |
| FY2024 | -$23.0M | +1.0% |
| FY2023 | -$23.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RDPTF financial trends
RDPTF RevenueRDPTF Net incomeRDPTF Net marginRDPTF Gross profitRDPTF Gross marginRDPTF Operating incomeRDPTF Operating marginRDPTF Free cash flowRDPTF Capital expendituresRDPTF Return on equityRDPTF Stock buybacksRDPTF Dividends paidRDPTF Total assetsRDPTF Total liabilitiesRDPTF Shareholders’ equityRDPTF overview →